Medroxyprogesterone - Revision history

Danbot: Fix cite error: add ACOG citation content to empty named ref

2026-03-21T01:01:44Z

Fix cite error: add ACOG citation content to empty named ref

← Older revision		Revision as of 01:01, 21 March 2026
Line 7:		Line 7:
	==Adult Dosing==		==Adult Dosing==
	===[[Non-pregnant vaginal bleeding]]===		===[[Non-pregnant vaginal bleeding]]===
	*'''20 mg PO TID for 7 days'''<ref name="ACOG" />		*'''20 mg PO TID for 7 days'''<ref name="ACOG">American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 557: Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women. Obstet Gynecol. 2013;121(4):891-896. doi:10.1097/01.AOG.0000428646.67925.9a</ref>
	**76% success, median time 3 days		**76% success, median time 3 days
	*Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days		*Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days

Rossdonaldson1 at 20:40, 24 January 2024

2024-01-24T20:40:03Z

← Older revision		Revision as of 20:40, 24 January 2024
Line 11:		Line 11:
	*Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days		*Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days
	**In a trial of 48 patients all had cessation in 5 days.<ref name="highdose">Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.</ref>		**In a trial of 48 patients all had cessation in 5 days.<ref name="highdose">Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.</ref>
	*Contraindications
	** History of [[VTE]]
	** History of arterial [[thromboembolic events]]
	** History of breast cancer
	** [[Liver disease]]

	==Pediatric Dosing==		==Pediatric Dosing==
Line 37:		Line 32:
	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
			* History of [[VTE]]
			* History of arterial [[thromboembolic events]]
			* History of breast cancer
			* Liver disease

	==Adverse Reactions==		==Adverse Reactions==

Rossdonaldson1: Created page with "==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ===Non-pregnant vaginal bleeding=== *'''20 mg PO TID for 7 days''' **76% success, median time 3 days *Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days **In a trial of 48 patients all had cessation in 5 days.Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient..."

2024-01-24T20:39:12Z

Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ===Non-pregnant vaginal bleeding=== *'''20 mg PO TID for 7 days'''<ref name="ACOG" /> **76% success, median time 3 days *Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days **In a trial of 48 patients all had cessation in 5 days.<ref name="highdose">Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient..."

New page

==Administration==
*Type:
*Dosage Forms:
*Routes of Administration:
*Common Trade Names:

==Adult Dosing==
===[[Non-pregnant vaginal bleeding]]===
*'''20 mg PO TID for 7 days'''<ref name="ACOG" />
**76% success, median time 3 days
*Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days
**In a trial of 48 patients all had cessation in 5 days.<ref name="highdose">Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.</ref>
*Contraindications
** History of [[VTE]]
** History of arterial [[thromboembolic events]]
** History of breast cancer
** [[Liver disease]]

==Pediatric Dosing==

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*

===Lactation risk===
*

===Renal Dosing===
*Adult:
*Pediatric:

===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]